Persistent strongyloidiasis in an immunodeficient patient.

Abstract

A 56-year-old woman with acquired, common variable immunodeficiency was found to have persistent gastrointestinal as well as pulmonary infection with Strongyloides stercoralis. Repeated courses of treatment with thiabendazole led to marked reduction or loss of Strongyloides stercoralis larvae, but cessation of treatment always led to recurrence of Strongyloides infection. Several small bowel biopsies showed normal villous architecture and little inflammatory response to presence of larvae. Interestingly, no definite symptomatology could be attributed to the Strongyloides infection. It was postulated that the lack of signs and symptoms of strongyloidiasis, as well as poor response to treatment, was related to the immunodeficiency state. With low-dose, long-term interrupted courses of thiabendazole treatment, the Strongyloides infection finally seemed to be cured.

• Authors: J H Shelhamer, F A Neva, D R Finn
• Journal: The American journal of tropical medicine and hygiene (Am J Trop Med Hyg) Vol. 31 Issue 4 Pg. 746-51 (Jul 1982) ISSN: 0002-9637 [Print] United States
• PMID: 7102907 (Publication Type: Case Reports, Journal Article)

Chemical References

• Immunoglobulins
• Mebendazole
• Thiabendazole

Topics

• Feces (parasitology)
• Female
• Humans
• Immunoglobulins (analysis)
• Immunologic Deficiency Syndromes (complications, parasitology)
• Intestine, Small (parasitology)
• Mebendazole (therapeutic use)
• Middle Aged
• Sputum (parasitology)
• Strongyloidiasis (complications, drug therapy, immunology)
• Thiabendazole (therapeutic use)